Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
GROWTH-HORMONE (GH) BINDING AND EFFECTS OF GH ANALOGS IN TRANSGENIC MICE
Autore:
BARTKE A; TURYN D; AGUILAR CC; SOTELO AI; STEGER RW; CHEN XZ; KOPCHICK JJ;
Indirizzi:
SO ILLINOIS UNIV,SCH MED,DEPT PHYSIOL CARBONDALE IL 62901 UNIV BUENOS AIRES,CONICET BUENOS AIRES ARGENTINA OHIO UNIV,EDISON ANIM BIOTECHNOL CTR ATHENS OH 45701
Titolo Testata:
Proceedings of the Society for Experimental Biology and Medicine
fascicolo: 3, volume: 206, anno: 1994,
pagine: 190 - 194
SICI:
0037-9727(1994)206:3<190:G(BAEO>2.0.ZU;2-Z
Fonte:
ISI
Lingua:
ENG
Soggetto:
GONADOTROPIN-SECRETION; EXTRACELLULAR DOMAIN; PITUITARY-FUNCTION; EXPRESSING HUMAN; GENE-EXPRESSION; FUSION GENES; FEMALE MICE; BOVINE; RECEPTORS; LIVERS;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Science Citation Index Expanded
Citazioni:
35
Recensione:
Indirizzi per estratti:
Citazione:
A. Bartke et al., "GROWTH-HORMONE (GH) BINDING AND EFFECTS OF GH ANALOGS IN TRANSGENIC MICE", Proceedings of the Society for Experimental Biology and Medicine, 206(3), 1994, pp. 190-194

Abstract

Overexpression of human (h) or bovine (b) growth hormone (GH) in transgenic mice is associated with marked (2- to 12-fold) and significant increase in hepatic binding of GH and prolactin (PRL). This is due to an increase in the number of GH and PRL receptors (GHR, PRLR) per mg of microsomal protein without changes in binding affinity. Comparison of results obtained in transgenic animals expressing bGH with a mouse metallothionein (MT) or a rat phosphoenolpyruvate carboxykinase (PEPCK)promoter suggests that effects of bGH on hepatic GHR and PRLR do not require GH overexpression during fetal life and, within the dose rangetested, the effects on PRLR are not dose dependent. The increase in hepatic GHR was accompanied by significant increases in plasma GH-binding protein (GHBP) and in mean residence time of injected GH. Thus lifelong elevation of peripheral GH levels alters the availability of both free GH and GHR. Site-directed in vitro mutagenesis was used to produce hGH and bGH analogs mutated within one of the sites involved in binding to GHR and PRLR. Mutating hGH to produce amino acid identity with bGH at Position 11, 18 (within Helix 1), 57, or 60 (within the loop between Helix 1 and 2) did not affect binding to GHR in vitro, or somatotropic activity in transgenic mice in vivo but reduced lactogenic activity in Nb-2 cells by 22%-45%. Mutations of bGH designed to produce amino acid identity with hGH at one to four of the corresponding positions in the bGH molecule did not interfere with binding to GHR or somatotropic activity in vivo, and failed to produce significant binding to PRLR but resulted in alterations in the effects on the hypothalamic and anterior pituitary function in transgenic mice. Apparently region(s) outside the domains examined are essential for lactogenic activity of hGH, and different portions of the GH molecule are responsible for its diverse actions in vivo.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/11/20 alle ore 06:02:39